The growing demand for GLP-1 drugs has led to a significant supply-demand imbalance, especially for highly sought-after obesity medications like tirzepatide and semaglutide
Please consult a medical professional before adopting any of the suggestions on this page
Stephens Francis B., Constantin-Teodosiu Dumitru, Laithwaite David, Simpson Elisabeth J., and Greenhaff Paul L
The short answer is: not necessarily, but it depends on your individual circumstances
You may experience a cluster of seemingly unrelated issues that have developed or worsened over time, leaving you feeling chronically unwell without a clear explanation
Moreover, Genistein, by reduction of pro-inflammatory mediators (IL-6, tumor necrosis factor- (TNF-) and C-reactive protein (CRP)) in serum and intestine in alloxan-induced diabetic rats, reduces the damage of L-cells and leads to an increase in the expression and secretion of GLP-1[191]